500 Boylston Street, Boston, MA 02116 617-419-4700
Return to Results
The purpose of the study is to collect additional information on the safety and
effectiveness of the CorPath 200 system now that it is cleared for use by physicians in the
delivery and manipulation of coronary guidewires and balloons/stents during percutaneous
coronary interventions. The study is designed to collect information from the routine use
of the CorPath 200 system.
Not yet recruiting
Ages:18 and older
Inclusion Criteria: 1. Age >18 years. 2. Patients with coronary artery disease undergoing Percutaneous Coronary Intervention (PCI) with the CorPath 200 system. 3. The subject or the legal representative has been informed of the nature of the study, agrees to its provisions and has provided written informed consent. Exclusion Criteria: 1. Concurrent enrollment in another device or drug study protocol that specifically excludes concurrent enrollment or that prevents collection of data required in this registry (concurrent participation in another registry is not an automatic exclusion criterion for this study). 2. Failure/inability/unwillingness to provide informed consent.
Sponsor: Corindus Inc.
Trial ID: NCT01917682
Not Accepting Healthy Volunteers